MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Botulinum injections for idiopathic cervical dystonia: a longitudinal study

G. Yahalom, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, L. Ephraty, S. Hassin-Baer (Jerusalem, Israel)

Meeting: MDS Virtual Congress 2021

Abstract Number: 136

Keywords: Botulinum toxin: Clinical applications: dystonia

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: In this retrospective longitudinal study, we explored the efficacy of repeated BT injection sessions for idiopathic cervical dystonia (ICD).

Background: Botulinum toxin (BT) injections into the cervical muscles are an effective and commonly practiced treatment approach for cervical dystonia.

Method: In this retrospective longitudinal study, we collected data form the Sheba electronic medical records on consecutive patients with idiopathic cervical dystonia (ICD), treated regularly with periodic BT injections between the years 2008-2020. All treatment visits were analyzed regarding type of toxin, dose, muscles injected and clinical outcomes.

Results: Sixty-four ICD patients [51 (79.7%) females, onset at age 45.9±13.9 years] were treated over 17.1±13.9 (range 3 to 49) visits per patient; BT treatment efficacy increased gradually from initial treatment sessions to visit 13, when it achieved a steady state. While the subjective report of percentage improvement and its duration, were around 78.9±17.1% for 2.8±1.0 months, respectively, the dose of BT increased significantly over the years (p=0.006), between visits 10-30.  Side effects (SE) were not rare, and commonly recurred after subsequent sessions and were usually mild and short-lasting, with dysphagia being the most common (~17.5%), followed by neck/arm weakness (11.9%) and cervical pain (8.9%).

Conclusion: Repeated injections of BT for ICD remain beneficial for patients over several years of therapy, and despite mild SE many patients adhere to a time schedule of 3-4 months interval.

To cite this abstract in AMA style:

G. Yahalom, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, L. Ephraty, S. Hassin-Baer. Botulinum injections for idiopathic cervical dystonia: a longitudinal study [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/botulinum-injections-for-idiopathic-cervical-dystonia-a-longitudinal-study/. Accessed November 11, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/botulinum-injections-for-idiopathic-cervical-dystonia-a-longitudinal-study/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley